| Magnetic drug targeting: a novel treatment for intramedullary spinal cord tumors P Kheirkhah, S Denyer, AD Bhimani, GD Arnone, DR Esfahani, T Aguilar, ... Scientific reports 8 (1), 11417, 2018 | 78 | 2018 |
| Magnetic field-enhanced cellular uptake of doxorubicin loaded magnetic nanoparticles for tumor treatment I Venugopal, S Pernal, A Duproz, J Bentley, H Engelhard, A Linninger Materials Research Express 3 (9), 095010, 2016 | 39 | 2016 |
| Implant-assisted intrathecal magnetic drug targeting to aid in therapeutic nanoparticle localization for potential treatment of central nervous system disorders E Lueshen, I Venugopal, T Soni, A Alaraj, A Linninger Journal of biomedical nanotechnology 11 (2), 253-261, 2015 | 39 | 2015 |
| Intrathecal magnetic drug targeting for localized delivery of therapeutics in the CNS I Venugopal, N Habib, A Linninger Nanomedicine 12 (8), 865-877, 2017 | 33 | 2017 |
| Intrathecal magnetic drug targeting using gold-coated magnetite nanoparticles in a human spine model E Lueshen, I Venugopal, J Kanikunnel, T Soni, A Alaraj, A Linninger Nanomedicine 9 (8), 1155-1169, 2014 | 30 | 2014 |
| Quantum dot conjugated magnetic nanoparticles for targeted drug delivery and imaging I Venugopal, S Pernal, T Fusinatto, D Ashkenaz, A Linninger Nano Biomed. Eng 8 (1), 24-38, 2016 | 10 | 2016 |
| Drug delivery applications of nanoparticles in the spine I Venugopal, AI Mehta, AA Linninger Drug Delivery Systems, 121-143, 2020 | 5 | 2020 |
| Tumor-specific intracellular delivery: peptide-guided transport of a catalytic toxin CA Allred, C Gormley, I Venugopal, S Li, MJ McGuire, KC Brown Communications Biology 6 (1), 60, 2023 | 2 | 2023 |
| Prototype biosensor for detection of myelin basic protein biomarker in hydrocephalus diagnosis I Venugopal, R Sirhan, S Basati, AA Linninger Sensor Letters 14 (1), 84-92, 2016 | 2 | 2016 |
| Computational modeling of intrathecal magnetic drug targeting for treatment of central nervous system diseases K Tangen, I Venugopal, A Linninger journal of cerebral blood flow and metabolism 37, 128-128, 2017 | 1 | 2017 |
| Intrathecal Magnetic Drug Targeting: A New Approach to Treating Diseases of the Central Nervous System E Lueshen, I Venugopal, A Linninger Boston, MA: ASME, 2013 | 1 | 2013 |
| CSF Flow Dynamics in Relation to Intrathecal Drug Transport AA Linninger, K Tangen, AO Ayansiji, DS Gehrke, I Venugopal, TL Yaksh, ... Neuraxial Therapeutics: A Comprehensive Guide, 223-253, 2024 | | 2024 |
| Targeted antigen delivery system and uses thereof KC Brown, MJ McGuire, I Venugopal US Patent App. 18/246,083, 2023 | | 2023 |
| 839 TALLTM (Targeted Antigen Loaded Liposomes) immunotherapy exploits recall immunity to form an excellent co-therapy option for immune checkpoint inhibitors I Venugopal, MN DeLong, AG Powell, S Knoche, MJ McGuire, KC Brown Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 190 Utilizing a peptide-based approach to target and evaluate novel biomarker Neu5Gc Sialyl Lewis A in cancer S Knoche, I Venugopal, MJ McGuire, KC Brown Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| Molecular transport system to the central nervous system KC Brown, M McGuire, I Venugopal US Patent App. 17/912,482, 2023 | | 2023 |
| Molecular guide system peptides and uses thereof KC Brown, M McGuire, S Li, I Venugopal, C Allred US Patent App. 17/766,109, 2022 | | 2022 |
| 618 Expanding cancer immunotherapy by exploiting recall immunity–A new co-therapy option for checkpoint inhibitors K Brown, M McGuire, A Pande, I Venugopal Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| Cancer-specific intracellular delivery of therapeutic antibodies against KRAS. MJ McGuire, S Li, I Venugopal, C Gormley, KJ Luebke, CA Allred, ... MOLECULAR CANCER RESEARCH 18 (5), 63-63, 2020 | | 2020 |
| Abstract B21: Cancer-specific intracellular delivery of therapeutic antibodies against KRAS MJ McGuire, S Li, I Venugopal, C Gormley, KJ Luebke, CA Allred, ... Molecular Cancer Research 18 (5_Supplement), B21-B21, 2020 | | 2020 |
Andreas LinningerUniversity of IllinoisVerified email at uic.edu
